Navigating the evolving role of immunotherapy in advanced endometrial carcinoma

touchPANEL DISCUSSION for touchONCOLOGY Listen to three leading international experts in gynaecological oncology as they discuss how immunotherapy is transforming the treatment of advanced endometrial carcinoma. The faculty explore how the latest data are shaping first-line treatment decisions, how to personalize therapy using biomarkers and molecular classification, and how to manage immune-related adverse events through practical monitoring strategies. The experts Prof. Isabelle Ray-Coquard, Centre Léon Bérard, Lyon, France Prof. Nicoletta Colombo, University of Milan-Bicocca, Milan, Italy Dr Brian Slomovitz, Mount Sinai Medical Center, Miami, FL, USA This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchoncologyime.org/panel-icis-in-ec/